281 related articles for article (PubMed ID: 26212128)
21. Neuropathology of Multiple System Atrophy, a Glioneuronal Degenerative Disease.
Wakabayashi K; Miki Y; Tanji K; Mori F
Cerebellum; 2024 Feb; 23(1):2-12. PubMed ID: 35474048
[TBL] [Abstract][Full Text] [Related]
22. The degree of astrocyte activation in multiple system atrophy is inversely proportional to the distance to α-synuclein inclusions.
Radford R; Rcom-H'cheo-Gauthier A; Wong MB; Eaton ED; Quilty M; Blizzard C; Norazit A; Meedeniya A; Vickers JC; Gai WP; Guillemin GJ; West AK; Dickson TC; Chung R; Pountney DL
Mol Cell Neurosci; 2015 Mar; 65():68-81. PubMed ID: 25731829
[TBL] [Abstract][Full Text] [Related]
23. Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.
Mandel RJ; Marmion DJ; Kirik D; Chu Y; Heindel C; McCown T; Gray SJ; Kordower JH
Acta Neuropathol Commun; 2017 Jun; 5(1):47. PubMed ID: 28619074
[TBL] [Abstract][Full Text] [Related]
24. FAS-dependent cell death in α-synuclein transgenic oligodendrocyte models of multiple system atrophy.
Kragh CL; Fillon G; Gysbers A; Hansen HD; Neumann M; Richter-Landsberg C; Haass C; Zalc B; Lubetzki C; Gai WP; Halliday GM; Kahle PJ; Jensen PH
PLoS One; 2013; 8(1):e55243. PubMed ID: 23372841
[TBL] [Abstract][Full Text] [Related]
25. BCAS1-positive immature oligodendrocytes are affected by the α-synuclein-induced pathology of multiple system atrophy.
Kaji S; Maki T; Ueda J; Ishimoto T; Inoue Y; Yasuda K; Sawamura M; Hikawa R; Ayaki T; Yamakado H; Takahashi R
Acta Neuropathol Commun; 2020 Jul; 8(1):120. PubMed ID: 32727582
[TBL] [Abstract][Full Text] [Related]
26. Multiple system atrophy: α-Synuclein strains at the neuron-oligodendrocyte crossroad.
Reddy K; Dieriks BV
Mol Neurodegener; 2022 Nov; 17(1):77. PubMed ID: 36435784
[TBL] [Abstract][Full Text] [Related]
27. Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes.
Kahle PJ; Neumann M; Ozmen L; Muller V; Jacobsen H; Spooren W; Fuss B; Mallon B; Macklin WB; Fujiwara H; Hasegawa M; Iwatsubo T; Kretzschmar HA; Haass C
EMBO Rep; 2002 Jun; 3(6):583-8. PubMed ID: 12034752
[TBL] [Abstract][Full Text] [Related]
28. alpha-synuclein is developmentally expressed in cultured rat brain oligodendrocytes.
Richter-Landsberg C; Gorath M; Trojanowski JQ; Lee VM
J Neurosci Res; 2000 Oct; 62(1):9-14. PubMed ID: 11002283
[TBL] [Abstract][Full Text] [Related]
29. alpha-Synuclein promotes the recruitment of tau to protein inclusions in oligodendroglial cells: effects of oxidative and proteolytic stress.
Riedel M; Goldbaum O; Richter-Landsberg C
J Mol Neurosci; 2009 Sep; 39(1-2):226-34. PubMed ID: 19266322
[TBL] [Abstract][Full Text] [Related]
30. Role of VAPB and vesicular profiles in α-synuclein aggregates in multiple system atrophy.
Mori F; Miki Y; Tanji K; Kon T; Tomiyama M; Kakita A; Wakabayashi K
Brain Pathol; 2021 Nov; 31(6):e13001. PubMed ID: 34196429
[TBL] [Abstract][Full Text] [Related]
31. A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy.
Spencer B; Valera E; Rockenstein E; Trejo-Morales M; Adame A; Masliah E
Mol Neurodegener; 2015 Sep; 10():48. PubMed ID: 26394760
[TBL] [Abstract][Full Text] [Related]
32. Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies.
Iwata A; Maruyama M; Akagi T; Hashikawa T; Kanazawa I; Tsuji S; Nukina N
Hum Mol Genet; 2003 Oct; 12(20):2625-35. PubMed ID: 12928483
[TBL] [Abstract][Full Text] [Related]
33. 17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagy.
Riedel M; Goldbaum O; Schwarz L; Schmitt S; Richter-Landsberg C
PLoS One; 2010 Jan; 5(1):e8753. PubMed ID: 20090920
[TBL] [Abstract][Full Text] [Related]
34. HDAC6 regulates aggresome-autophagy degradation pathway of α-synuclein in response to MPP+-induced stress.
Su M; Shi JJ; Yang YP; Li J; Zhang YL; Chen J; Hu LF; Liu CF
J Neurochem; 2011 Apr; 117(1):112-20. PubMed ID: 21235576
[TBL] [Abstract][Full Text] [Related]
35. The neuropathology of multiple system atrophy and its therapeutic implications.
Valera E; Masliah E
Auton Neurosci; 2018 May; 211():1-6. PubMed ID: 29169744
[TBL] [Abstract][Full Text] [Related]
36. Slow Progressive Accumulation of Oligodendroglial Alpha-Synuclein (α-Syn) Pathology in Synthetic α-Syn Fibril-Induced Mouse Models of Synucleinopathy.
Uemura N; Uemura MT; Lo A; Bassil F; Zhang B; Luk KC; Lee VM; Takahashi R; Trojanowski JQ
J Neuropathol Exp Neurol; 2019 Oct; 78(10):877-890. PubMed ID: 31504665
[TBL] [Abstract][Full Text] [Related]
37. Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy.
Giasson BI; Mabon ME; Duda JE; Montine TJ; Robertson D; Hurtig HI; Lee VM; Trojanowski JQ
Acta Neuropathol; 2003 Sep; 106(3):243-50. PubMed ID: 12811584
[TBL] [Abstract][Full Text] [Related]
38. Oxidative stress-induced phosphorylation, degradation and aggregation of alpha-synuclein are linked to upregulated CK2 and cathepsin D.
Takahashi M; Ko LW; Kulathingal J; Jiang P; Sevlever D; Yen SH
Eur J Neurosci; 2007 Aug; 26(4):863-74. PubMed ID: 17714183
[TBL] [Abstract][Full Text] [Related]
39. Cystatin C triggers neuronal degeneration in a model of multiple system atrophy.
Suzuki Y; Jin C; Yazawa I
Am J Pathol; 2014 Mar; 184(3):790-9. PubMed ID: 24405769
[TBL] [Abstract][Full Text] [Related]
40. Fatty acid-binding protein 7 triggers α-synuclein oligomerization in glial cells and oligodendrocytes associated with oxidative stress.
Cheng A; Wang YF; Shinoda Y; Kawahata I; Yamamoto T; Jia WB; Yamamoto H; Mizobata T; Kawata Y; Fukunaga K
Acta Pharmacol Sin; 2022 Mar; 43(3):552-562. PubMed ID: 33935286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
